Overview

Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy

Status:
Not yet recruiting
Trial end date:
2023-11-28
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, placebo-controlled, parallel-designed, multiple-site, bioequivalence study with clinical endpoints.
Phase:
Phase 3
Details
Lead Sponsor:
Teva Pharmaceuticals USA
Treatments:
Estradiol